Rapamycin control of transgene expression from a single AAV vector in mouse salivary glands

This publication has 22 references indexed in Scilit:

• Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer
  Blood, 2005
• Salivary glands: novel target sites for gene therapeutics
  Trends in Molecular Medicine, 2004
• Reengineered salivary glands are stable endogenous bioreactors for systemic gene therapeutics
  Proceedings of the National Academy of Sciences, 2004
• Rapamycin control of exocrine protein levels in saliva after adenoviral vector-mediated gene transfer
  Gene Therapy, 2004
• Intravenous administration of an AAV-2 vector for the expression of factor IX in mice and a dog model of hemophilia B
  Gene Therapy, 2004
• Local Adeno-Associated Virus-Mediated Interleukin 10 Gene Transfer Has Disease-Modifying Effects in a Murine Model of Sjögren's Syndrome
  Human Gene Therapy, 2003
• Recombinant Adeno-Associated Virus Serotype 2 Vectors Mediate Stable Interleukin 10 Secretion from Salivary Glands into the Bloodstream
  Human Gene Therapy, 2002
• Repetitive Adenovirus Administration to the Parotid Gland: Role of Immunological Barriers and Induction of Oral Tolerance
  Human Gene Therapy, 1998
• Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein
  Proceedings of the National Academy of Sciences, 1996
• A humanized system for pharmacologic control of gene expression
  Nature Medicine, 1996